Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar
BioTalk Unzipped2 Joulu 2024

Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar

Dr. Tomas Helikar, a leading researcher in bioinformatics and systems biology, delves into groundbreaking work on developing a personalized immune digital twin, which aims to revolutionize the understanding and treatment of immune-related diseases.

Chapters

00:00 Introduction to BioTalk Unzipped

01:50 Meet Dr. Tomas Helikar

04:34 The Journey into Systems Biology

10:03 Understanding Digital Twins in Immunology

14:19 The Importance of Personalized Medicine

17:20 Digital Twin Research Funding and Its Impact

18:38 The Role of Digital Twins in Disease Management

21:11 Digital Twin Efforts for Organ Transplants

24:05 Computational Challenges in Modeling

26:36 Mathematical Models in Biological Research

28:11 - NEW NEWS! - Twist Joins Absci in AI Antibody Collaboration

How to reach us:

Tomas Helikar

https://www.linkedin.com/in/tomashelikar/

X - https://x.com/tomashelikar

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Charity Mentioned: https://saintpeterlincoln.com/school

FOLLOW ►

LinkedIn: https://www.linkedin.com/company/biotalk-unzipped

Twitter: https://x.com/BiotalkUnzipped

Instagram: https://www.instagram.com/biotalkunzipped/

Takeaways

  • Dr. Helikar's research focuses on the immune system's network and disease.
  • Systems biology integrates computer science and biology for better understanding.
  • Digital twins can provide personalized models for immune system analysis.
  • Your digital twin model could tell you how you might respond to a particular disease and if you really need to go to the hospital.
  • The immune digital twin reflects an individual's unique immune baseline.
  • Research funding is crucial for advancing innovative medical technologies.
  • Personalized medicine can improve public health outcomes significantly.
  • Computational power is essential for processing complex biological data.
  • Mathematical models are vital for simulating biological processes.
  • Digital twins can enhance drug discovery and clinical trial efficiency.

Sound Bites

"The immune system is a network of networks."

“Each of our immune system baselines are different.”

"We need to build out this multi-scale model."

New News Story:


Image Credits


Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Elo 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Heinä 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Kesä 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Huhti 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Maalis 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Helmi 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Joulu 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Loka 202531min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
rss-inderes
ostan-asuntoja-podcast
hyva-paha-johtaminen
rss-sami-miettinen-neuvottelija
rss-porssipuhetta
rss-ammattipodcast
rahapuhetta
sijoituspodi
rss-oivalluksia-rahasta-elamasta
pomojen-suusta
rss-karon-grilli
rss-kaupan-tila
rss-hilden-kaira
rss-porssipodi
oppimisen-psykologia
rss-paasipodi